Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Mikael Dolsten > Profile

Mikael Dolsten

Affiliations

  • at Rocket Pharmaceuticals Inc. (RCKT), 2025-04-24
  • Director at Agilent Technologies Inc. (A), 2025-03-18
  • President R&D at Pfizer Inc (PFE), 2024-09-16
  • Director at Karyopharm Therapeutics Inc. (KPTI), 2021-05-21
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PFE $49.31 32,015 $1,578,659.65 333,342 2022-05-11 Filing
PFE $49.32 18,562 $915,477.84 365,357 2022-05-11 Filing
PFE $49.33 7,876 $388,523.08 383,919 2022-05-11 Filing
PFE $49.35 2,891 $142,670.85 391,795 2022-05-11 Filing
PFE $49.34 2,358 $116,343.72 394,686 2022-05-11 Filing